Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.14.99.20 extracted from

  • Brunner-Ziegler, S.; Jilma, B.; Magirr, D.; Sunder-Plassmann, R.; Giurgea, G.A.; Hammer, A.; Margeta, C.; Brunner, M.; Koppensteiner, R.; Mannhalter, C.
    Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy a pilot study (2014), Br. J. Haematol., 167, 547-553 .
    View publication on PubMed

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
phylloquinone + reduced acceptor + O2 Homo sapiens
-
2,3-epoxyphylloquinone + acceptor + H2O
-
?

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
phylloquinone + reduced acceptor + O2
-
Homo sapiens 2,3-epoxyphylloquinone + acceptor + H2O
-
?

Synonyms

Synonyms Comment Organism
vitamin K epoxide reductase complex subunit 1
-
Homo sapiens
VKORC1
-
Homo sapiens